Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Triple combination of metformin, DPP4 inhibitor and Thiazolidinedione would be a good option in the treatment of drug-naïve Korean type 2 diabetic patients. Newly developed thiazolidinedione, Lobeglitazone would be not inferior to Pioglitazone.
Epistemonikos ID: b824b3945f7a4ed3f579f4c3fd2e1035de39ad06
First added on: May 12, 2024